Innomind Drug Patent Portfolio
Innomind owns 1 orange book drug protected by 2 US patents Given below is the list of Innomind's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11666573 | Dosage regimen of paliperidone palmitate extended-release injectable suspension | 24 Sep, 2039 | Active |
| US12128049 | Dosage regimen of paliperidone palmitate extended-release injectable suspension | 26 Oct, 2038 | Active |
Latest Legal Activities on Innomind's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Innomind.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 29 Oct, 2024 | US12128049 |
| Recordation of Patent eGrant | 29 Oct, 2024 | US12128049 |
| Patent Issue Date Used in PTA Calculation | 29 Oct, 2024 | US12128049 |
| Mail Patent eGrant Notification | 29 Oct, 2024 | US12128049 |
| Email Notification | 29 Oct, 2024 | US12128049 |
| Patent eGrant Notification | 29 Oct, 2024 | US12128049 |
| Issue Notification Mailed | 09 Oct, 2024 | US12128049 |
| Email Notification | 09 Oct, 2024 | US12128049 |
| Application Is Considered Ready for Issue | 26 Sep, 2024 | US12128049 |
| Dispatch to FDC | 26 Sep, 2024 | US12128049 |
| Issue Fee Payment Received | 25 Sep, 2024 | US12128049 |
| Issue Fee Payment Verified | 25 Sep, 2024 | US12128049 |
| Email Notification | 18 Sep, 2024 | US12128049 |
| Filing Receipt - Replacement | 18 Sep, 2024 | US12128049 |
| Mail Notice of Allowance | 12 Sep, 2024 | US12128049 |
Innomind's Family Patents
Innomind Drug List
Given below is the complete list of Innomind's drugs and the patents protecting them.
1. Erzofri
Erzofri is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11666573 | Dosage regimen of paliperidone palmitate extended-release injectable suspension |
24 Sep, 2039
(13 years from now)
| Active |
| US12128049 | Dosage regimen of paliperidone palmitate extended-release injectable suspension |
26 Oct, 2038
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Erzofri's drug page